CClinicalTrials.gg
CompletedNCT00534235Updated Feb 6, 2020Results posted

Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis

An interventional study of Decompression and Posterolateral Fusion and Implantation of Pedicle Screws in Spinal Stenosis, sponsored by Paradigm Spine. Completed. Per ClinicalTrials.gov, last updated 2020-02-06.

Sponsored by Paradigm Spine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
322
Allocation
Randomized
01

Study summary

Post-Approval Clinical Study Comparing the Long Term Safety and Effectiveness of coflex vs. Fusion to Treat Lumbar Spinal Stenosis

Read the detailed description

The primary objective of this post-approval study is to examine the long-term survivorship of the coflex®. The coflex® Interlaminar Technology is an interlaminar stabilization device indicated for use in one or two level lumbar stenosis from L1-L5 in skeletally mature patients with at least moderate impairment in function, who experience relief in flexion from their symptoms of leg/buttocks/groin pain, with or without back pain, and who have undergone at least 6 months of non-operative treatment. The coflex® is intended to be implanted midline between adjacent lamina of 1 or 2 contiguous lumbar motion segments. Interlaminar stabilization is performed after decompression of stenosis at the affected level(s).

02

Conditions studied

03

In context

Spinal Stenosis

459 studies on the registry are indexed under Spinal Stenosis; 103 are open to participants now.

This study's enrollment of 322 is above the median of 80 across 283 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Paradigm Spine is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Accepts healthy volunteers
No
This record does not list eligibility criteria. Contact the study team before assuming you do or do not qualify.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
322 participants (actual)

Study arms

  • Active comparator
    Posterolateral Fusion w/Pedicle Screws

    Control: Posterolateral fusion and implantation of pedicle screws after decompression

    Procedure: Decompression · Device: Posterolateral Fusion and Implantation of Pedicle Screws

  • Active comparator
    coflex Interlaminar Technolgy

    Investigative: Implantation of coflex Interlaminar Technology after decompression

    Procedure: Decompression · Device: Implantation of coflex Interlaminar Technology

Interventions

  • ProcedureDecompression

    Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain

  • DevicePosterolateral Fusion and Implantation of Pedicle Screws
  • DeviceImplantation of coflex Interlaminar Technology
06

What researchers measure

Primary outcomes

  1. Number of Subjects With Improvement of at Least 15 Points in ODI

    The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).

    Time frame: 5 years

  2. Number of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation

    Assessment of secondary surgical interventions, i.e., reoperations, revisions, removals, or supplemental fixation associated with either coflex or control group. Refer to FDA guidance for complete definitions (https://www.fda.gov/RegulatoryInformation/Guidances/ucm072263.htm).

    Time frame: 5 years

  3. Number of Subjects With no Major Device Related Complications

    Assessment of major device-related complications at 5 years

    Time frame: 5 years

  4. Number of Subjects With no Epidural Injection(s)

    Assessment of lumbar epidural injections

    Time frame: 5 years

  5. Number of Subjects With no Persistent New or Increasing Sensory or Motor Deficit

    No persistent new or increasing sensory or motor deficit

    Time frame: 5 years

  6. Number of Subjects With no Persistent New or Increasing Sensory Deficit

    No persistent new or increasing sensory deficit

    Time frame: 5 years

  7. Number of Subjects With no Persistent New or Increasing Motor Deficit

    No persistent new or increasing motor deficit

    Time frame: 5 years

  8. Number of Subjects With no Reoperations or Epidural (Up to Day 1825)

    No reoperations, revisions, removals or supplemental fixation and no epidural injection at any lumbar level up to and including the Month 60 visit.

    Time frame: 5 years

Secondary outcomes

  1. Number of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points

    ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

    Time frame: 5 years

  2. Number of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points

    ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis.

    Time frame: 5 years

  3. Number of Subjects With Maintenance or Improvement in SF-12 Physical Function Component

    Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

    Time frame: 5 years

  4. Number of Subjects With Maintenance or Improvement in SF-12 Mental Health Component

    Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

    Time frame: 5 years

  5. Number of Subjects With a Decrease in VAS Back Pain of at Least 20mm

    Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

    Time frame: 5 years

  6. Number of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm

    Improvement of the Visual Analog Scale (VAS) for leg pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

    Time frame: 5 years

  7. Mean Oswestry Disability Index (ODI) Score

    Assessment of disability from low back pain as measured by ODI (Oswestry Disability Index) mean score in each treatment group at 5 years. On a scale of 0-100, a higher score represents increased disability.

    Time frame: 5 years

  8. Mean Visual Analog Scale Back Pain Score

    Assessment of Back Pain as measured by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

    Time frame: 5 years

  9. Mean Visual Analog Scale Leg (Worse) Pain Score

    Assessment of Worse Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

    Time frame: 5 years

  10. Mean Visual Analog Scale (VAS) Leg (Right) Pain Score

    Assessment of Right Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

    Time frame: 5 years

  11. Mean Visual Analog Scale (VAS) Leg (Left) Pain Score

    Assessment of Left Leg Pain by VAS mean score in both treatment groups at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

    Time frame: 5 years

  12. Number of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm

    Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

    Time frame: 5 years

  13. Number of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm

    Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

    Time frame: 5 years

  14. Mean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score

    Assessment of symptom severity by ZCQ mean score in both treatment groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

    Time frame: 5 years

  15. Mean Zurich Claudication Questionnaire (ZCQ) Physical Function Score

    Assessment of physical function by ZCQ mean score in both groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

    Time frame: 5 years

  16. Mean Short Form-12 Physical Component Score

    Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

    Time frame: 5 years

  17. Mean Short Form-12 Mental Component Score

    Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

    Time frame: 5 years

  18. Patient Survey: Satisfaction

    Subjects who responded "Very Satisfied" or "Somewhat Satisfied".

    Time frame: 5 years

  19. Patient Survey: Recommendation of Treatment

    Subjects who responded "Definitely Yes" or "Probably Yes"

    Time frame: 5 years

  20. Pain Management: Class II Narcotics Usage by Device Group

    Number of subjects using Class II narcotics

    Time frame: 5 years

  21. Pain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group

    Number of subjects using NSAIDs/ASA/Acetaminophen

    Time frame: 5 years

Other outcomes

  1. Mean Rotation (F to E) in Degrees - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  2. Rotation (F to E) in Degrees - Below Level of Implant

    As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level below the implant in both treatment groups at 5 years.

    Time frame: 5 years

  3. Rotation (F to E) in Degrees - Above Level of Implant

    As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level above the implant in both treatment groups at 5 years.

    Time frame: 5 years

  4. Translation (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average measure of translation at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  5. Translation (mm) - Below Level of Implant

    As determined by independent radiographic lab, this is the average measure of translation at the level below the implant in both treatment groups at 5 years.

    Time frame: 5 years

  6. Translation (mm) - Above Level of Implant

    As determined by independent radiographic lab, this is the average measure of translation at the level above the implant in both treatment groups at 5 years.

    Time frame: 5 years

  7. Anterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average measure of anterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  8. Posterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average measure of posterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  9. Translation (F to E) in Percent (%) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the percentage of translation at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  10. Translation (F to E) in Percent (%) - Below Level of Implant

    As determined by independent radiographic lab, this is the percentage of translation at the level below the implant in both treatment groups at 5 years.

    Time frame: 5 years

  11. Translation (F to E) in Percent (%) - Above Level of Implant

    As determined by independent radiographic lab, this is the percentage of translation at the level above the implant in both treatment groups at 5 years.

    Time frame: 5 years

  12. Average Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average measure of disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  13. Change From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from baseline for anterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  14. Change From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from baseline for posterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  15. Change From Pre-Op Average Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from baseline for disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  16. Change From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from immediate post-op for anterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  17. Change From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from immediate post-op for posterior disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  18. Change From Post-Op Average Disc Height (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the average change from immediate post-op for disc height at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  19. Disc Angle in Degrees - At Level(s) of Implant

    As determined by independent radiographic lab, this is the mean disc angle at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  20. Change From Pre-Op Disc Angle in Degrees - At Level(s) of Implant

    As determined by independent radiographic lab, this is the mean change in disc angle from baseline at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  21. Change From Post-Op Disc Angle in Degrees - At Level(s) of Implant

    As determined by independent radiographic lab, this is the mean change in disc angle from immediate post-op at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  22. Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  23. Change From Post-Op Spondylolisthesis (%) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the measure of the percentage of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  24. Change From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  25. Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant

    As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis from immediate post-op at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  26. Foraminal Height (X-ray) (mm) - At Level(s) of Implant

    This is the mean foraminal height via x-ray at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  27. Change From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant

    This is the mean change in foraminal height via x-ray from baseline at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  28. Change From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant

    This is the mean change in foraminal height via x-ray from immediate post-op at the index level(s) in both treatment groups at 5 years.

    Time frame: 5 years

  29. Bony Bridging

    Bridging through the posterolateral gutters, between the facet joints, between transverse processes, and/or between facet joint and transverse process will all be considered acceptable forms of bridging bone.

    Time frame: 5 years

  30. Heterotopic Ossification

    Assessment applicable to coflex arm only. The assessment applies to bony formations that occur in and around the implant.

    Time frame: 5 years

  31. Fusion Status

    The assessment is an analysis of three component factors: Bridging Bone, Angular Motion and Translational Motion.

    Time frame: 5 years

  32. Interface Remodeling - At Level(s) of Implant

    Per level; Assessment applicable to coflex arm only. This is an assessment of the bone-implant interface.

    Time frame: 5 years

  33. Device Condition (Coflex Arm)

    Per level; Assessment only applicable to coflex group. Device Condition in the investigational subjects was graded as: Intact, Deformed, Fractured, Migrated, or Dislodged.

    Time frame: 5 years

  34. Device Condition (Fusion Control)

    Per level; This assessment is applicable to the fusion arm only. Device Condition in the control subjects will be graded as: Intact, Loose Screws, or Failed Hardware.

    Time frame: 5 years

  35. Device Mobility

    Per level; Assessment is applicable to coflex arm only. Device Mobility is an expected occurrence in some subjects and represents the amount of the of lift-off of the implant from the inferior spinous process.

    Time frame: 5 years

07

Results

Posted Feb 27, 2019

Participant flow

Participant flow — Overall Study
MilestonePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Started107215
Completed91192
Not completed1623

Outcome measures

PrimaryNumber of Subjects With Improvement of at Least 15 Points in ODI

The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With Improvement of at Least 15 Points in ODI
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With Improvement of at Least 15 Points in ODI41101
PrimaryNumber of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation

Assessment of secondary surgical interventions, i.e., reoperations, revisions, removals, or supplemental fixation associated with either coflex or control group. Refer to FDA guidance for complete definitions (https://www.fda.gov/RegulatoryInformation/Guidances/ucm072263.htm).

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation87179
PrimaryNumber of Subjects With no Major Device Related Complications

Assessment of major device-related complications at 5 years

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Major Device Related Complications
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Major Device Related Complications100212
PrimaryNumber of Subjects With no Epidural Injection(s)

Assessment of lumbar epidural injections

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Epidural Injection(s)
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Epidural Injection(s)84177
PrimaryNumber of Subjects With no Persistent New or Increasing Sensory or Motor Deficit

No persistent new or increasing sensory or motor deficit

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Persistent New or Increasing Sensory or Motor Deficit
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Persistent New or Increasing Sensory or Motor Deficit70135
PrimaryNumber of Subjects With no Persistent New or Increasing Sensory Deficit

No persistent new or increasing sensory deficit

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Persistent New or Increasing Sensory Deficit
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Persistent New or Increasing Sensory Deficit72137
PrimaryNumber of Subjects With no Persistent New or Increasing Motor Deficit

No persistent new or increasing motor deficit

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Persistent New or Increasing Motor Deficit
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Persistent New or Increasing Motor Deficit72144
PrimaryNumber of Subjects With no Reoperations or Epidural (Up to Day 1825)

No reoperations, revisions, removals or supplemental fixation and no epidural injection at any lumbar level up to and including the Month 60 visit.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With no Reoperations or Epidural (Up to Day 1825)
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With no Reoperations or Epidural (Up to Day 1825)71149
SecondaryNumber of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points

ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points40100
SecondaryNumber of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points

ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points3898
SecondaryNumber of Subjects With Maintenance or Improvement in SF-12 Physical Function Component

Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With Maintenance or Improvement in SF-12 Physical Function Component
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With Maintenance or Improvement in SF-12 Physical Function Component3493
SecondaryNumber of Subjects With Maintenance or Improvement in SF-12 Mental Health Component

Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With Maintenance or Improvement in SF-12 Mental Health Component
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With Maintenance or Improvement in SF-12 Mental Health Component3172
SecondaryNumber of Subjects With a Decrease in VAS Back Pain of at Least 20mm

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With a Decrease in VAS Back Pain of at Least 20mm
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With a Decrease in VAS Back Pain of at Least 20mm40104
SecondaryNumber of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm

Improvement of the Visual Analog Scale (VAS) for leg pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm4199
SecondaryMean Oswestry Disability Index (ODI) Score

Assessment of disability from low back pain as measured by ODI (Oswestry Disability Index) mean score in each treatment group at 5 years. On a scale of 0-100, a higher score represents increased disability.

Time frame:
5 years
Reported as:
Mean · units on a scale
Mean Oswestry Disability Index (ODI) Score
units on a scalePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Oswestry Disability Index (ODI) Score26.1 ± 22.224.5 ± 20.5
SecondaryMean Visual Analog Scale Back Pain Score

Assessment of Back Pain as measured by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Time frame:
5 years
Reported as:
Mean · mm
Mean Visual Analog Scale Back Pain Score
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Visual Analog Scale Back Pain Score29.0 ± 31.025.4 ± 27.6
SecondaryMean Visual Analog Scale Leg (Worse) Pain Score

Assessment of Worse Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Time frame:
5 years
Reported as:
Mean · mm
Mean Visual Analog Scale Leg (Worse) Pain Score
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Visual Analog Scale Leg (Worse) Pain Score25.2 ± 31.222.8 ± 28.1
SecondaryMean Visual Analog Scale (VAS) Leg (Right) Pain Score

Assessment of Right Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Time frame:
5 years
Reported as:
Mean · mm
Mean Visual Analog Scale (VAS) Leg (Right) Pain Score
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Visual Analog Scale (VAS) Leg (Right) Pain Score16.0 ± 24.514.9 ± 21.6
SecondaryMean Visual Analog Scale (VAS) Leg (Left) Pain Score

Assessment of Left Leg Pain by VAS mean score in both treatment groups at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Time frame:
5 years
Reported as:
Mean · mm
Mean Visual Analog Scale (VAS) Leg (Left) Pain Score
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Visual Analog Scale (VAS) Leg (Left) Pain Score17.0 ± 26.818.4 ± 27.0
SecondaryNumber of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm3690
SecondaryNumber of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Number of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm3778
SecondaryMean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score

Assessment of symptom severity by ZCQ mean score in both treatment groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Time frame:
5 years
Reported as:
Mean · units on a scale
Mean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score
units on a scalePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score2.17 ± 0.852.08 ± 0.84
SecondaryMean Zurich Claudication Questionnaire (ZCQ) Physical Function Score

Assessment of physical function by ZCQ mean score in both groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Time frame:
5 years
Reported as:
Mean · units on a scale
Mean Zurich Claudication Questionnaire (ZCQ) Physical Function Score
units on a scalePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Zurich Claudication Questionnaire (ZCQ) Physical Function Score1.81 ± 0.791.67 ± 0.68
SecondaryMean Short Form-12 Physical Component Score

Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

Time frame:
5 years
Reported as:
Mean · units on a scale
Mean Short Form-12 Physical Component Score
units on a scalePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Short Form-12 Physical Component Score42.1 ± 12.642.1 ± 11.2
SecondaryMean Short Form-12 Mental Component Score

Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

Time frame:
5 years
Reported as:
Mean · units on a scale
Mean Short Form-12 Mental Component Score
units on a scalePosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Short Form-12 Mental Component Score54.8 ± 8.454.1 ± 9.7
SecondaryPatient Survey: Satisfaction

Subjects who responded "Very Satisfied" or "Somewhat Satisfied".

Time frame:
5 years
Reported as:
Count of participants · Participants
Patient Survey: Satisfaction
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Patient Survey: Satisfaction72151
SecondaryPatient Survey: Recommendation of Treatment

Subjects who responded "Definitely Yes" or "Probably Yes"

Time frame:
5 years
Reported as:
Count of participants · Participants
Patient Survey: Recommendation of Treatment
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Patient Survey: Recommendation of Treatment70145
SecondaryPain Management: Class II Narcotics Usage by Device Group

Number of subjects using Class II narcotics

Time frame:
5 years
Reported as:
Count of participants · Participants
Pain Management: Class II Narcotics Usage by Device Group
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Pain Management: Class II Narcotics Usage by Device Group1732
SecondaryPain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group

Number of subjects using NSAIDs/ASA/Acetaminophen

Time frame:
5 years
Reported as:
Count of participants · Participants
Pain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group
ParticipantsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Pain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group2455
Other pre-specifiedMean Rotation (F to E) in Degrees - At Level(s) of Implant

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Mean Rotation (F to E) in Degrees - At Level(s) of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Mean Rotation (F to E) in Degrees - At Level(s) of Implant0.98 ± 1.173.13 ± 3.43
Other pre-specifiedRotation (F to E) in Degrees - Below Level of Implant

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level below the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Rotation (F to E) in Degrees - Below Level of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Rotation (F to E) in Degrees - Below Level of Implant5.62 ± 3.695.83 ± 4.17
Other pre-specifiedRotation (F to E) in Degrees - Above Level of Implant

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level above the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Rotation (F to E) in Degrees - Above Level of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Rotation (F to E) in Degrees - Above Level of Implant3.59 ± 2.893.52 ± 3.16
Other pre-specifiedTranslation (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average measure of translation at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Translation (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (mm) - At Level(s) of Implant0.23 ± 0.320.82 ± 0.84
Other pre-specifiedTranslation (mm) - Below Level of Implant

As determined by independent radiographic lab, this is the average measure of translation at the level below the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Translation (mm) - Below Level of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (mm) - Below Level of Implant0.63 ± 0.570.64 ± 0.61
Other pre-specifiedTranslation (mm) - Above Level of Implant

As determined by independent radiographic lab, this is the average measure of translation at the level above the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Translation (mm) - Above Level of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (mm) - Above Level of Implant0.69 ± 0.570.83 ± 0.80
Other pre-specifiedAnterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average measure of anterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Anterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Anterior Disc Height (mm) - At Level(s) of Implant8.13 ± 3.198.89 ± 3.68
Other pre-specifiedPosterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average measure of posterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Posterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Posterior Disc Height (mm) - At Level(s) of Implant4.56 ± 1.654.46 ± 1.89
Other pre-specifiedTranslation (F to E) in Percent (%) - At Level(s) of Implant

As determined by independent radiographic lab, this is the percentage of translation at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · percent
Translation (F to E) in Percent (%) - At Level(s) of Implant
percentPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (F to E) in Percent (%) - At Level(s) of Implant0.69 ± 0.892.38 ± 2.43
Other pre-specifiedTranslation (F to E) in Percent (%) - Below Level of Implant

As determined by independent radiographic lab, this is the percentage of translation at the level below the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · percent
Translation (F to E) in Percent (%) - Below Level of Implant
percentPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (F to E) in Percent (%) - Below Level of Implant1.95 ± 1.951.97 ± 1.88
Other pre-specifiedTranslation (F to E) in Percent (%) - Above Level of Implant

As determined by independent radiographic lab, this is the percentage of translation at the level above the implant in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · percent
Translation (F to E) in Percent (%) - Above Level of Implant
percentPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Translation (F to E) in Percent (%) - Above Level of Implant2.07 ± 1.682.40 ± 2.31
Other pre-specifiedAverage Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average measure of disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Average Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Average Disc Height (mm) - At Level(s) of Implant6.34 ± 2.096.67 ± 2.45
Other pre-specifiedChange From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from baseline for anterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant-1.38 ± 1.58-1.32 ± 1.75
Other pre-specifiedChange From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from baseline for posterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant-0.49 ± 1.19-0.72 ± 1.26
Other pre-specifiedChange From Pre-Op Average Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from baseline for disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Pre-Op Average Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Pre-Op Average Disc Height (mm) - At Level(s) of Implant-0.93 ± 1.02-1.02 ± 1.24
Other pre-specifiedChange From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from immediate post-op for anterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant-1.82 ± 1.39-0.98 ± 2.06
Other pre-specifiedChange From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from immediate post-op for posterior disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant-0.85 ± 1.00-1.90 ± 1.65
Other pre-specifiedChange From Post-Op Average Disc Height (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the average change from immediate post-op for disc height at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Average Disc Height (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Average Disc Height (mm) - At Level(s) of Implant-1.33 ± 0.97-1.44 ± 1.47
Other pre-specifiedDisc Angle in Degrees - At Level(s) of Implant

As determined by independent radiographic lab, this is the mean disc angle at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Disc Angle in Degrees - At Level(s) of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Disc Angle in Degrees - At Level(s) of Implant6.02 ± 4.647.28 ± 5.19
Other pre-specifiedChange From Pre-Op Disc Angle in Degrees - At Level(s) of Implant

As determined by independent radiographic lab, this is the mean change in disc angle from baseline at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Change From Pre-Op Disc Angle in Degrees - At Level(s) of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Pre-Op Disc Angle in Degrees - At Level(s) of Implant-1.41 ± 3.10-1.00 ± 2.91
Other pre-specifiedChange From Post-Op Disc Angle in Degrees - At Level(s) of Implant

As determined by independent radiographic lab, this is the mean change in disc angle from immediate post-op at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · degrees
Change From Post-Op Disc Angle in Degrees - At Level(s) of Implant
degreesPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Disc Angle in Degrees - At Level(s) of Implant-1.57 ± 2.251.56 ± 3.82
Other pre-specifiedChange From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant-1.08 ± 3.37-1.01 ± 3.78
Other pre-specifiedChange From Post-Op Spondylolisthesis (%) - At Level(s) of Implant

As determined by independent radiographic lab, this is the measure of the percentage of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · percent
Change From Post-Op Spondylolisthesis (%) - At Level(s) of Implant
percentPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Spondylolisthesis (%) - At Level(s) of Implant-3.4 ± 9.9-3.2 ± 11.2
Other pre-specifiedChange From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant-0.12 ± 2.28-0.56 ± 1.82
Other pre-specifiedChange From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant

As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis from immediate post-op at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
mmPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant-0.77 ± 1.92-0.44 ± 1.91
Other pre-specifiedForaminal Height (X-ray) (mm) - At Level(s) of Implant

This is the mean foraminal height via x-ray at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Foraminal Height (X-ray) (mm) - At Level(s) of Implant
mmCoflex Interlaminar Technolgy
Foraminal Height (X-ray) (mm) - At Level(s) of Implant17.33 ± 2.75
Other pre-specifiedChange From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant

This is the mean change in foraminal height via x-ray from baseline at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
mmCoflex Interlaminar Technolgy
Change From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant-0.47 ± 1.29
Other pre-specifiedChange From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant

This is the mean change in foraminal height via x-ray from immediate post-op at the index level(s) in both treatment groups at 5 years.

Time frame:
5 years
Reported as:
Mean · mm
Change From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
mmCoflex Interlaminar Technolgy
Change From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant-1.81 ± 1.74
Other pre-specifiedBony Bridging

Bridging through the posterolateral gutters, between the facet joints, between transverse processes, and/or between facet joint and transverse process will all be considered acceptable forms of bridging bone.

Time frame:
5 years
Reported as:
Count of units · Levels
Bony Bridging
LevelsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
NA0209
No170
Yes840
Indeterminate100
Other pre-specifiedHeterotopic Ossification

Assessment applicable to coflex arm only. The assessment applies to bony formations that occur in and around the implant.

Time frame:
5 years
Reported as:
Number · participants
Heterotopic Ossification
participantsCoflex Interlaminar Technolgy
NA0
None91
Grade I0
Grade II24
Grade III73
Bony Bridging3
Indeterminate18
Other pre-specifiedFusion Status

The assessment is an analysis of three component factors: Bridging Bone, Angular Motion and Translational Motion.

Time frame:
5 years
Reported as:
Count of units · Levels
Fusion Status
LevelsPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
NA00
Not fused19196
Fused783
Indeterminate1410
Other pre-specifiedInterface Remodeling - At Level(s) of Implant

Per level; Assessment applicable to coflex arm only. This is an assessment of the bone-implant interface.

Time frame:
5 years
Reported as:
Count of units · Levels
Interface Remodeling - At Level(s) of Implant
LevelsCoflex Interlaminar Technolgy
NA0
None75
Mild70
Moderate16
Severe20
Indeterminate28
Other pre-specifiedDevice Condition (Coflex Arm)

Per level; Assessment only applicable to coflex group. Device Condition in the investigational subjects was graded as: Intact, Deformed, Fractured, Migrated, or Dislodged.

Time frame:
5 years
Reported as:
Count of units · Levels
Device Condition (Coflex Arm)
LevelsCoflex Interlaminar Technolgy
NA0
Intact184
Deformed0
Fractured3
Migrated11
Dislodged0
Indeterminate11
Other pre-specifiedDevice Condition (Fusion Control)

Per level; This assessment is applicable to the fusion arm only. Device Condition in the control subjects will be graded as: Intact, Loose Screws, or Failed Hardware.

Time frame:
5 years
Reported as:
Count of units · Levels
Device Condition (Fusion Control)
LevelsPosterolateral Fusion w/Pedicle Screws
NA0
Intact90
Failed Graft0
Loose Screws10
Fractured Hardware2
Indeterminate9
Other pre-specifiedDevice Mobility

Per level; Assessment is applicable to coflex arm only. Device Mobility is an expected occurrence in some subjects and represents the amount of the of lift-off of the implant from the inferior spinous process.

Time frame:
5 years
Reported as:
Count of units · Levels
Device Mobility
LevelsCoflex Interlaminar Technolgy
NA0
< 5 mm181
>= 5 mm15
Indeterminate13

Adverse events

Collected over 5 years. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Posterolateral Fusion w/Pedicle Screws0/107 (0%)64/107 (59.8%)101/107 (94.4%)
Coflex Interlaminar Technolgy0/215 (0%)109/215 (50.7%)199/215 (92.6%)
Most frequent serious events
Showing 10 of 22
Most frequent serious events
EventPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
Pain; new, increased frequency, or worseningMusculoskeletal and connective tissue disorders19/10729/215
MusculoskeletalMusculoskeletal and connective tissue disorders16/10732/215
OtherMetabolism and nutrition disorders11/10710/215
Cancer/NeoplasmNeoplasms benign, malignant and unspecified (incl cysts and polyps)10/1075/215
CardiovascularCardiac disorders5/10717/215
GastrointestinalGastrointestinal disorders6/10710/215
Component LooseningMusculoskeletal and connective tissue disorders5/1073/215
GenitourinaryGeneral disorders5/1075/215
NeurologicalNervous system disorders4/1075/215
Psychiatric/Substance AbusePsychiatric disorders3/1070/215
Most frequent other events
Showing 10 of 23
Most frequent other events
EventPosterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar Technolgy
MusculoskeletalMusculoskeletal and connective tissue disorders65/107119/215
Pain; new, increased frequency, or worseningMusculoskeletal and connective tissue disorders29/10761/215
NeurologicalNervous system disorders23/10756/215
OtherMusculoskeletal and connective tissue disorders20/10746/215
Wound problemsMusculoskeletal and connective tissue disorders9/10724/215
CardiovascularCardiac disorders11/10715/215
GastrointestinalGastrointestinal disorders11/10711/215
Skin and Subcutaneous TissueSkin and subcutaneous tissue disorders9/10716/215
GenitourinaryGeneral disorders8/10711/215
RespiratoryRespiratory, thoracic and mediastinal disorders7/1077/215

Baseline characteristics

Age, Continuous
Age, Continuous(years)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Mean64.1 ± 9.062.1 ± 9.262.8 ± 9.2
Sex: Female, Male
Sex: Female, Male(Participants)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Female58106164
Male49109158
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
American Indian / Alaskan Native314
Asian347
Black or African American61117
White93191284
Other2810
Region of Enrollment
Region of Enrollment(participants)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
United States107215322
Weight
Weight(pounds)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Mean187.7 ± 38.1190.3 ± 35.4189.5 ± 36.3
Height
Height(inches)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Mean66.6 ± 4.167.0 ± 4.166.9 ± 4.1
Current Smoker
Current Smoker(Participants)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Yes152237
No92193285
Comorbidities
Comorbidities(Participants)Posterolateral Fusion w/Pedicle ScrewsCoflex Interlaminar TechnolgyTotal
Cardiovascular74137211
Musculoskeletal61112173
Endocrine355590

4 further baseline measures are reported on the registry.

08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Davis R, Auerbach JD, Bae H, Errico TJ. Can low-grade spondylolisthesis be effectively treated by either coflex interlaminar stabilization or laminectomy and posterior spinal fusion? Two-year clinical and radiographic results from the randomized, prospective, multicenter US investigational device exemption trial: clinical article. J Neurosurg Spine. 2013 Aug;19(2):174-84. doi: 10.3171/2013.4.SPINE12636. Epub 2013 May 31. PubMed 23725394 ↗

Related links

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00534235
Lead sponsor
Paradigm Spine
Collaborators
MCRA
Responsible party
Sponsor
First posted
Sep 24, 2007
Start date
Oct 2012
Primary completion
Dec 2015
Completion
Dec 2015
Results posted
Feb 27, 2019
Last update
Feb 6, 2020

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion